A new study published online today by Pediatrics and conducted by researchers at the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital found that from January 2007 through December 2016 there were more than 11,000 calls to US Poison Centers for pediatric exposures to buprenorphine.
High speed and throughput Convincing performance Benchtop and cabinet design Flexible workbench setupIntuitive and flexible software Cost-effective
Blood grouping/ reverse grouping/ phenotyping/ crossmatching/ antibody screening/ antibody identification/ direct AHG test(DAT)/ single antigens/Rh(D) Rh(CcEe)/Newborn-ABO-Rh/ Rh/k/ ABO DD/Kell/ AHG Polyspecific/ ADK
Rodeman
UCP Biosciences, Inc.—a leading supplier of In Vitro Diagnostics (IVD)—offers top notch Point of Care Testing (POCT) devices ranging from instant urine and saliva drug tests (in the U.S. Market) to Infectious Disease, Women’s Health, Cardiac Markers, and Tumor Markers (in the International Market).
Health care insurers including Medicare, Medicaid and major private insurers have not done enough to combat the opioid epidemic, suggests a study led by researchers at Johns Hopkins Bloomberg School of Public Health.
In this issue, find research on Prop. 47 and drug arrests, teen self-injury, LGBQ substance abuse, women’s tobacco use, public housing and asthma
Baebies, a growth-stage company that delivers innovative products and services for newborn screening and pediatric testing, today announced that it has secured $10 million in Series B financing in an oversubscribed round anchored by BOE Technology Group Co., Ltd.
Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, announced today it has received de novo clearance from the U.S. Food and Drug Administration (FDA) for SEEKER. SEEKER quantitatively measures the activity of lysosomal enzymes α-L-iduronidase (IDUA), α-D-glucosidase (GAA), β-glucocerebrosidase (GBA) and α-D-galactosidase A (GLA) from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of lysosomal storage diseases (LSDs) Mucopolysaccharidosis Type I (MPS I), Pompe, Gaucher or Fabry, respectively.
Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, announced the first assays on the FINDER launch panel, currently under development. The panel includes tests for total serum bilirubin, albumin, direct bilirubin, and glucose-6-phosphate dehydrogenase (G6PD) on a single cartridge, making it the first comprehensive, rapid and near-patient testing solution for hyperbilirubinemia. A robust pipeline of future panels for other disorders using the same cartridge on FINDER is also in development.
Baebies is pleased to announce that SEEKERTM, a high throughput newborn screening laboratory solution, now has CE Mark and available in Europe and other countries that recognize CE Mark. SEEKER quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens.
Rutgers Professor Stephen Crystal, who co-authored a pioneering study showing that U.S. survivors of opioid overdoses are highly likely to die within a year from drug use–related causes, suicide and wide-ranging diseases, is available for interviews. The study was published online in JAMA Psychiatry today.
Globe Scientific is celebrating its 35th year as the trusted name in laboratory supplies!
Gay and bisexual men are disproportionately affected by HIV/AIDS illness and death in the U.S., accounting for 70 percent of new HIV infections. Furthermore, among men who have sex with men (MSM), black MSM are disproportionately at risk of HIV infection. Alcohol consumption may play a role in HIV transmission because it can lead individuals to have sex without using a condom. This study examined the links between condom use and drinking, before and during sex, and alcohol-use problems.
Intimate partner violence (IPV) is prevalent, affecting individuals from adolescence through adulthood. While alcohol is a known contributing cause of IPV, researchers are examining why some individuals who drink become violent but others who drink do not. These results and others will be shared at the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21.
A new study, led by Dr Andrew Kunzmann, researcher from the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast, has found the combined risk of death and developing a number of cancers is lowest in light drinkers, consuming less than one drink per day, and increases with each additional drink per week.
BÜHLMANN Laboratories AG, is proud to announce it has received United States Food and Drug Administration (FDA) 510(k) clearance of its BÜHLMANN fCAL® ELISA.
Adolescence is a critical time for development of the brain, as well as accompanying cognitive and socioemotional abilities. It is also a time of high media activity. Results of the Adolescent Brain Cognitive Development (ABCD) study that examined the effects of media activity on psychopathology among youth will be shared at the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21.
Alcohol hangovers are more significant and costly than people realize, new research shows. Although individuals may be “street legal” to drive a car, or go to work and operate machinery, they can be just as impaired with a hangover as if they were over the alcohol limit. These observations and others will be shared at the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21.
Aim Lab is making the automation of sample tube processing more accessible with their PathFinder 350D Decapper/Sorter and PathFinder 350A Archiver compact robotic workstations.
DRG International, a leading international medical diagnostic company, will showcase its DRG® Aldosterone ELISA Kit at the 2018 AACC Conference in Chicago, Illinois from July 29 – August 2. The DRG International Aldosterone ELISA is for measurement of Aldosterone in serum, plasma, and urine.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG® Saliva ELISA Assays at the 2018 AACC in Chicago, IL from July 31 – August 2. DRG is also introducing for the first time the NEW Hepcidin Salivary ELISA Kit (SLV-6082).
DRG International’s Renin (Active) ELISA for testing of active Renin in human EDTA plasma will be on display at the AACC’s 2018 show in Chicago, Illinois from July 29 – August 2. The DRG® Renin active ELISA test is accurate in testing for certain types of hypertension and has been utilized by labs world-wide.
DRG International, a leading international medical diagnostic company, will showcase the NEW DRG® Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782R) at the 2018 AACC Conference in Chicago, Illinois from July 29 – August 2. As the first of its kind to market, this kit accurately detects bioactive Hepcidin levels as an additional marker to aid in identifying a variety of disorders.
DRG International, a leading international medical diagnostic company, will showcase the NEW DRG® Hepcidin Salivary ELISA Kit (SLV-6082) at the 2018 AACC Conference in Chicago, Illinois from July 29 – August 2. As the first of its kind to market, this kit accurately detects bioactive Hepcidin levels in saliva samples as an additional marker to aid in identifying a variety of disorders.
“Pregaming” is defined as drinking alone or with other people before going to an event or get-together where alcohol may be present. Pregaming often involves rapid drinking, which can quickly produce high blood alcohol concentrations (BACs) that meet or exceed the legal limit for intoxication. It is a common, high-risk drinking activity among college students that remains largely unaffected by efforts to reduce its occurrence. This study sought to identify profiles of pregamers to characterize the specific risks associated with the behavior, and to develop more effective prevention strategies on college campuses.
Cooperative learning refers to group-based learning activities that teachers can use to encourage academic involvement and achievement while simultaneously addressing deviant peer influences that may lead to alcohol use. Early results form a study of middle schools in Oregon show significant reductions in alcohol and tobacco use as well as deviant peer friendships. These results and others will be shared at the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21.
Many people have opinions about alcoholism and alcoholics, but few have heard the stories of those afflicted with the disease. A plenary session at the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21 will feature three persons in recovery who have agreed to share their stories.
Despite common stereotypes, alcohol treatment is not limited to attending Alcoholics Anonymous (AA) meetings or “going to rehab.” A growing number of alcohol-treatment services in the U.S. are available as outpatient sessions with counselors and physicians; and now they can be found through NIAAA's Alcohol Treatment Navigator. These options and other real-world advice will be shared at the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21.
Alcohol dependence, and opiate, cocaine and other stimulant addictions, are all diseases of the brain that have behavioral manifestations and they are not due to criminal behavior alone or to antisocial or "weak" personality disorders. These observations and others will be shared during the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21.
Psychologists who are trained and experienced in treating alcohol problems can play an important role in treatment of both the affected individual as well as his or her family. This insight and others will be shared at the 41st annual scientific meeting of the Research Society on Alcoholism (RSA) in San Diego June 17-21.
The 41st annual scientific meeting of the Research Society on Alcoholism (RSA) will take place in San Diego June 17-20. RSA 2018 provides a meeting place for scientists and clinicians from across the country, and around the world, to interact. The meeting also gives members and non-members the chance to present their latest findings in alcohol research through abstract and symposia submissions. Below are seven programming highlights. Full press releases available upon request.
Impulsivity is broadly described as the tendency to act without prior thought. It is often linked to alcohol misuse in college students. However, impulsivity is a complex concept and it is likely that different subtypes of this psychological construct are associated with different patterns of alcohol misuse. This study examined links among several categories of impulsivity with both the frequency of alcohol consumption and the frequency of alcohol intoxication.
LGC Maine Standards1 releases the only comprehensive body fluids kit on the market, VALIDATE® Body Fluids, Order Number 205ro, for easier linearity and calibration verification.
LGC Maine Standards1 releases VALIDATE® HbA1c linearity and calibration verification kit, for Tosoh analyzers, Order Number 605to.
LGC Maine Standards1 releases VALIDATE® Procalcitonin linearity and calibration verification kit, for Roche cobas® analyzers, Order Number 403ro. The kit, in a human-serum matrix, evaluates Procalcitonin (PCT).
LGC Maine Standards1 announces VALIDATE® Fibrinogen for easier linearity and calibration verification on IL ACL TOP® 500 (Order No. 904il), Siemens Sysmex® CS-2500 (Order No. 904se), and Stago STA-R® Evolution (Order No. 904st) hemostasis test systems.
LGC Maine Standards1 releases VALIDATE® Procalcitonin linearity and calibration verification kit, for Abbott ARCHITECT analyzers, Order Number 403ab. The kit, in a human-serum matrix, evaluates Procalcitonin (PCT).
NovoPath’s AP LIS Receives Frost & Sullivan Technology Leadership Award for its Advanced Features that Transform AP Laboratory Workflow
Mount Sinai Researchers Discover That Aggressive Behavior and the Motivation to Act Aggressively Have Distinct Molecular Bases; Finding Suggests Possibility of Reducing Aggression by Targeting a Protein Associated with Addiction in a Reward Region of the Brain
While the opioid epidemic may feel too massive a problem to tackle or too overwhelming to even comprehend, experts in many corners of Penn Medicine are at work combating the deadly toll, including the physicians and researchers of the Center for Health Incentives and Behavioral Economics (CHIBE) at the Perelman School of Medicine. As one of two Roybal Centers on Behavioral Economics and Health nationally funded by the National Institute of Aging of NIH, CHIBE combines psychology and economics with clinical expertise in an effort to understand why individuals make certain decisions that impact their health and how to leverage their findings to advance policy, improve health care delivery, and encourage healthy behaviors among patients and best practices among clinicians. All those elements combine in their efforts to curb prescription opioid misuse.
Going on 20 years, the expertise of DIARECT AG is the design, manufacture and sales of recombinant and native antigens to the global IVD market. We provide our customers with over 150 antigens, and our product range is constantly expanding.
Going on 20 years, the expertise of DIARECT AG is the design, manufacture and sales of recombinant and native antigens to the global IVD market. We provide our customers with over 150 antigens, and our product range is constantly expanding.
Alcohol use and alcohol-use disorders in the U.S. greatly increased between 2001 and 2013, particularly among African-American emerging adults (i.e., those 18-29 years of age). Previous research showed that African American youth are unequally exposed to risk factors for substance use such as economic pressures, neighborhood disorder, and racial discrimination. This study examined how African American mothers’ protective parenting and alcohol use influenced their offspring’s drinking and perceptions of drinkers.
Systematic review of task-related neuroimaging studies found addicted individuals demonstrate increased activity in these networks during drug-related processing but decreases across all other functions
Ginolis, an innovative provider of assembly automation, liquid handling and quality inspection solutions, is pleased to announce the launch of Pixie, a standard system for automated optical quality inspection.
High school seniors who use heroin commonly use multiple other drugs—and not just opioids, according to a study by the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU Meyers College of Nursing.
Epitope Diagnostics is proud to introduce a new adrenocortocotropic hormone (ACTH) ELISA Kit, which measures ACTH levels with high sensitivity and robust assay performance characteristics.
This compact EPC-100 Reader Combines Crystal Clear Image Quality, fast scanning Speed and Affordability The new EPC-100 Rapid Test Cassette Reader features technology advances that result in the highest possible signal collection efficiency—providing the quantitative image and qualitative accuracy needed for diagnostic screenings.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right